We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Further Misanalysis of Urinalysis—Reply

Kathryn B. Holroyd1; Alexander Rittenberg, MD1; Amit Pahwa, MD1
[+] Author Affiliations
1The Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Intern Med. 2016;176(9):1408. doi:10.1001/jamainternmed.2016.4510.
Text Size: A A A
Published online


In Reply We would like to thank Dr Drekonja for his commentary on our article1 and agree that screening for or treatment of asymptomatic bacteriuria from chronic indwelling urinary catheters is not recommended by the Infectious Diseases Society of America (IDSA). In the 2005 IDSA guidelines2 on asymptomatic bacteriuria, the recommended strength is grade A-I (ie, “Good evidence to support a recommendation for use; should always be offered” based on “evidence from ≥ 1 randomized, controlled trial”). Our manuscript, however, mentioned a different condition termed asymptomatic persistent catheter-acquired bacteriuria. The same 2005 asymptomatic bacteriuria guidelines2 go on to state that “Antimicrobial treatment of asymptomatic women with catheter-acquired bacteriuria that persists 48 [hours] after catheter removal may be considered” and carries grade B-I recommendation strength (ie, “Moderate evidence to support a recommendation for use; should generally be offered”). Notably, in the subsequent 2009 IDSA guidelines3 on catheter-associated urinary tract infections, this recommendation was downgraded to grade C-I (ie, “Poor evidence to support a recommendation for…use”).


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2016
Dimitri Drekonja, MD, MS
1Minneapolis Veterans Affairs Healthcare System, Minneapolis, Minnesota
JAMA Intern Med. 2016;176(9):1407. doi:10.1001/jamainternmed.2016.4503.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...